Decision-makers in England agree to fund Fintepla for TSC-related condition Lennox-Gastaut Syndrome
The National Institute of Health and Social Care Excellence (NICE) has approved funding of fenfluramine (brand name Fintepla, developed by UCB Pharma) on NHS England to treat seizures associated with Lennox-Gastaut Syndrome (LGS), a rare epilepsy that some people with TSC also have. This